Milestones of Parkinson's Disease Research: 200 Years of History and Beyond.
作者信息
Li Song, Le Weidong
机构信息
Liaoning Provincial Center for Clinical Research on Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, Dalian, 116021, China.
Liaoning Provincial Key Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, Dalian, 116011, China.
出版信息
Neurosci Bull. 2017 Oct;33(5):598-602. doi: 10.1007/s12264-017-0178-2. Epub 2017 Sep 11.
Abstract
摘要
相似文献
1
Milestones of Parkinson's Disease Research: 200 Years of History and Beyond.帕金森病研究的里程碑：200年的历史及未来
Neurosci Bull. 2017 Oct;33(5):598-602. doi: 10.1007/s12264-017-0178-2. Epub 2017 Sep 11.
2
Did parkinsonism occur before 1817?帕金森氏症在1817年之前就已出现了吗？
J Neurol Neurosurg Psychiatry. 1989 Jun;Suppl(Suppl):11-2. doi: 10.1136/jnnp.52.suppl.11.
3
Historical crossroads in the conceptual delineation of apathy in Parkinson's disease.帕金森病中淡漠概念界定的历史转折点。
Brain. 2018 Feb 1;141(2):613-619. doi: 10.1093/brain/awx362.
4
Chapter 33: the history of movement disorders.第33章：运动障碍病史。
Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.
5
TCM: Made in China.中医：中国制造。
Nature. 2011 Dec 21;480(7378):S82-3. doi: 10.1038/480S82a.
6
Travelogue.旅行见闻录
Int J Surg Pathol. 2010 Jun;18(3 Suppl):20S-26S. doi: 10.1177/1066896910365215.
7
History of neurology. Foreword.神经学历史。前言。
Handb Clin Neurol. 2010;95:vii-viii. doi: 10.1016/S0072-9752(08)02159-3.
8
Academy affirms hockey-stick graph.学会确认曲棍球棒图。
Nature. 2006 Jun 29;441(7097):1032-3. doi: 10.1038/4411032a.
9
Hospitals of History.历史上的医院。
Circulation. 2016 Nov 1;134(18):1307. doi: 10.1161/CIRCULATIONAHA.116.025698.
10
A name with a heritage.一个有着传承的名字。
Vet Rec. 2011 Mar 26;168(12):331-2. doi: 10.1136/vr.d1656.
引用本文的文献
1
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.帕金森病：弥合差距、构建生物标志物及重塑临床转化
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.
2
Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons' Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach.大黄素，一种强效蒽醌，通过调节Nrf2及其下游靶点减轻MPTP诱导的帕金森病病理：计算机模拟和体内实验方法
Mol Neurobiol. 2025 Feb 20. doi: 10.1007/s12035-025-04762-3.
3
Bibliometric analysis of Naunyn-Schmiedeberg's Archives of Pharmacology (1947-1974).药理学文献计量分析（1947-1974 年）。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):7141-7168. doi: 10.1007/s00210-024-03078-8. Epub 2024 Apr 23.
4
Defining Parkinson's Disease: Past and Future.定义帕金森病：过去与未来。
J Parkinsons Dis. 2024;14(s2):S257-S271. doi: 10.3233/JPD-230411.
5
Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system.重新审视神经退行性疾病：将脂质氧化与中枢神经系统疾病联系起来的神经代谢概念。
Neural Regen Res. 2024 Jul 1;19(7):1437-1445. doi: 10.4103/1673-5374.387965. Epub 2023 Nov 8.
6
Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment.帕金森病中的多巴胺激动剂：D1样或D2样多巴胺受体亚型选择性的影响及未来治疗途径
Clin Park Relat Disord. 2023 Jul 7;9:100212. doi: 10.1016/j.prdoa.2023.100212. eCollection 2023.
7
Effectiveness of deep brain stimulation in Parkinson's disease treatment with Single-center experience in Pakistan.脑深部电刺激治疗帕金森病的有效性：巴基斯坦单中心经验
Pak J Med Sci. 2023 Jul-Aug;39(4):1018-1023. doi: 10.12669/pjms.39.4.7680.
8
Neurodegenerative disorders and gut-brain interactions.神经退行性疾病与肠脑相互作用。
J Clin Invest. 2021 Jul 1;131(13). doi: 10.1172/JCI143775.
9
Targeting PTB as a One-Step Procedure for In Situ Astrocyte-to-Dopamine Neuron Reprogramming in Parkinson's Disease.将PTB作为帕金森病原位星形胶质细胞向多巴胺能神经元重编程的一步法靶点。
Neurosci Bull. 2021 Mar;37(3):430-432. doi: 10.1007/s12264-021-00630-x. Epub 2021 Jan 13.
10
Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson's disease.全外显子组测序在一个中国早发性帕金森病家系中发现了一个新的 PRKN 复合杂合突变。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20200534.
本文引用的文献
1
Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.迷走神经切断术与帕金森病：一项基于瑞典登记册的匹配队列研究。
Neurology. 2017 May 23;88(21):1996-2002. doi: 10.1212/WNL.0000000000003961. Epub 2017 Apr 26.
2
The two-century journey of Parkinson disease research.帕金森病研究的两个世纪历程。
Nat Rev Neurosci. 2017 Mar 17;18(4):251-259. doi: 10.1038/nrn.2017.25.
3
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.由结合淋巴细胞激活基因3引发的病理性α-突触核蛋白传播。
Science. 2016 Sep 30;353(6307). doi: 10.1126/science.aah3374.
4
Cell-based therapies for Parkinson disease—past insights and future potential.基于细胞的帕金森病疗法——过去的见解和未来的潜力。
Nat Rev Neurol. 2015 Sep;11(9):492-503. doi: 10.1038/nrneurol.2015.123. Epub 2015 Aug 4.
5
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.全基因组关联数据的大规模荟萃分析确定了帕金森病的六个新风险位点。
Nat Genet. 2014 Sep;46(9):989-93. doi: 10.1038/ng.3043. Epub 2014 Jul 27.
6
Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.神经退行性疾病中致病性蛋白的细胞间传递。
Nat Med. 2014 Feb;20(2):130-8. doi: 10.1038/nm.3457.
7
The Parkinson disease before James Parkinson.帕金森病在詹姆斯·帕金森之前。
Neurol Sci. 2012 Aug;33(4):945-8. doi: 10.1007/s10072-011-0816-9. Epub 2011 Oct 18.
8
Neural grafting in Parkinson's disease Problems and possibilities.帕金森病中的神经移植：问题与可能。
Prog Brain Res. 2010;184:265-94. doi: 10.1016/S0079-6123(10)84014-2.
9
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.PINK1 依赖性募集 Parkin 到线粒体进行线粒体自噬。
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):378-83. doi: 10.1073/pnas.0911187107. Epub 2009 Dec 4.
10
The description of all four cardinal signs of Parkinson's disease in a Hungarian medical text published in 1690.1690 年出版的匈牙利医学文本中对帕金森病的所有四个主要征象的描述。
Parkinsonism Relat Disord. 2010 May;16(4):290-3. doi: 10.1016/j.parkreldis.2009.11.006. Epub 2009 Nov 30.
Zotero 插件